457 related articles for article (PubMed ID: 33304747)
1. DNA Nanostructures and DNA-Functionalized Nanoparticles for Cancer Theranostics.
Nicolson F; Ali A; Kircher MF; Pal S
Adv Sci (Weinh); 2020 Dec; 7(23):2001669. PubMed ID: 33304747
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Nanoplatforms Comprising Organic Nanocompartments Encapsulating Inorganic Nanoparticles for Enhanced Drug Delivery and Bioimaging Applications.
Yanar F; Carugo D; Zhang X
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570666
[TBL] [Abstract][Full Text] [Related]
3. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
Ma Y; Huang J; Song S; Chen H; Zhang Z
Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
[TBL] [Abstract][Full Text] [Related]
4. Surface Engineering of Nanoparticles toward Cancer Theranostics.
Huang P; Wang C; Deng H; Zhou Y; Chen X
Acc Chem Res; 2023 Jul; 56(13):1766-1779. PubMed ID: 37314368
[TBL] [Abstract][Full Text] [Related]
5. Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics.
Rabaan AA; Bukhamsin R; AlSaihati H; Alshamrani SA; AlSihati J; Al-Afghani HM; Alsubki RA; Abuzaid AA; Al-Abdulhadi S; Aldawood Y; Alsaleh AA; Alhashem YN; Almatouq JA; Emran TB; Al-Ahmed SH; Nainu F; Mohapatra RK
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557793
[TBL] [Abstract][Full Text] [Related]
6. Progress in Nanotheranostics Based on Mesoporous Silica Nanomaterial Platforms.
Singh RK; Patel KD; Leong KW; Kim HW
ACS Appl Mater Interfaces; 2017 Mar; 9(12):10309-10337. PubMed ID: 28274115
[TBL] [Abstract][Full Text] [Related]
7. "Trojan Horse" DNA Nanostructure for Personalized Theranostics: Can It Knock on the Door of Preclinical Practice?
Li Y; Yang S; Zheng J; Zou Z; Yang R; Tan W
Langmuir; 2018 Dec; 34(49):15028-15044. PubMed ID: 30295491
[TBL] [Abstract][Full Text] [Related]
8. Smart Gold Nanostructures for Light Mediated Cancer Theranostics: Combining Optical Diagnostics with Photothermal Therapy.
Tabish TA; Dey P; Mosca S; Salimi M; Palombo F; Matousek P; Stone N
Adv Sci (Weinh); 2020 Aug; 7(15):1903441. PubMed ID: 32775148
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in porous nanostructures for cancer theranostics.
Wang J; Zhang B; Sun J; Hu W; Wang H
Nano Today; 2021 Jun; 38():. PubMed ID: 33897805
[TBL] [Abstract][Full Text] [Related]
10. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.
Chen Q; Liu Z
Adv Mater; 2016 Dec; 28(47):10557-10566. PubMed ID: 27111654
[TBL] [Abstract][Full Text] [Related]
11. Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications.
Živojević K; Mladenović M; Djisalov M; Mundzic M; Ruiz-Hernandez E; Gadjanski I; Knežević NŽ
J Control Release; 2021 Sep; 337():193-211. PubMed ID: 34293320
[TBL] [Abstract][Full Text] [Related]
12. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
Tripathi P; Shukla P; Bieberich E
Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
[TBL] [Abstract][Full Text] [Related]
13. Construction of rolling circle amplification products-based pure nucleic acid nanostructures for biomedical applications.
Li C; Wang Y; Li PF; Fu Q
Acta Biomater; 2023 Apr; 160():1-13. PubMed ID: 36764595
[TBL] [Abstract][Full Text] [Related]
14. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
Cai Y; Chen X; Si J; Mou X; Dong X
Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnological selection.
Demming A
Nanotechnology; 2013 Jan; 24(2):020201. PubMed ID: 23242125
[TBL] [Abstract][Full Text] [Related]
16. Engineered Polymer Nanoplatforms for Targeted Tumor Cells and Controlled Release Cargos to Enhance Cancer Treatment.
Wang Z; Tang L; Mu Q; Che S; Sun Y; Bai L; Luo Y; Yang Y; Yu M; Yu Z
Curr Med Chem; 2021; 28(31):6395-6410. PubMed ID: 33634752
[TBL] [Abstract][Full Text] [Related]
17. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
18. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
[TBL] [Abstract][Full Text] [Related]
19. Chemical Modification of Chitosan for Developing Cancer Nanotheranostics.
Li X; Wang Y; Feng C; Chen H; Gao Y
Biomacromolecules; 2022 Jun; 23(6):2197-2218. PubMed ID: 35522524
[TBL] [Abstract][Full Text] [Related]
20. Pnictogen Semimetal (Sb, Bi)-Based Nanomaterials for Cancer Imaging and Therapy: A Materials Perspective.
Yu X; Liu X; Yang K; Chen X; Li W
ACS Nano; 2021 Feb; 15(2):2038-2067. PubMed ID: 33486944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
